A phase II trial of ifosfamide/mesna with doxorubicin for malignant mesothelioma
- 1 May 1989
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (5) , 911-912
- https://doi.org/10.1016/0277-5379(89)90141-7
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Malignant Pleural Mesothelioma: Phase II Pilot Study of Ifosfamide and Mesna*JNCI Journal of the National Cancer Institute, 1988
- A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcomaCancer Chemotherapy and Pharmacology, 1988
- Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patientsCancer Treatment Reviews, 1983